Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick R Harrington

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|November 19, 2011
Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatmentPatrick R Harrington, Wen Zeng, Lisa K Naeger
Hepatology (Baltimore, Md.)|July 19, 2012
Reply: To PMID 22095516Patrick R Harrington, Lisa K Naeger, Wen Zeng
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Closing in on the target: sustained virologic response in hepatitis C virus genotype 1 infection response-guided therapyErik Lontok, Nina Mani, Patrick R Harrington, et al.
Journal of Virology|June 16, 2005
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cellsPatrick R Harrington, David W Haas, Kimberly Ritola, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 2, 2006
Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspectiveAnnelies Van Rie, Patrick R Harrington, Anna Dow, et al.
Antiviral Research|November 5, 2013
Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathwaysTakashi E Komatsu, Andreas Pikis, Lisa K Naeger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic AssaysPatrick R Harrington, Takashi E Komatsu, Hengrui Sun, et al.
Journal of Virology|March 3, 2004
Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactionsPatrick R Harrington, Jan Vinjé, Christine L Moe, et al.
Journal of Virology|March 3, 2007
Independent evolution of human immunodeficiency virus type 1 env V1/V2 and V4/V5 hypervariable regions during chronic infectionPatrick R Harrington, Julie A E Nelson, Kathryn M Kitrinos, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvirEric F Donaldson, Patrick R Harrington, Julian J O'Rear, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|November 19, 2011
Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatmentPatrick R Harrington, Wen Zeng, Lisa K Naeger
Hepatology (Baltimore, Md.)|July 19, 2012
Reply: To PMID 22095516Patrick R Harrington, Lisa K Naeger, Wen Zeng
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Closing in on the target: sustained virologic response in hepatitis C virus genotype 1 infection response-guided therapyErik Lontok, Nina Mani, Patrick R Harrington, et al.
Journal of Virology|June 16, 2005
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cellsPatrick R Harrington, David W Haas, Kimberly Ritola, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 2, 2006
Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspectiveAnnelies Van Rie, Patrick R Harrington, Anna Dow, et al.
Antiviral Research|November 5, 2013
Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathwaysTakashi E Komatsu, Andreas Pikis, Lisa K Naeger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic AssaysPatrick R Harrington, Takashi E Komatsu, Hengrui Sun, et al.
Journal of Virology|March 3, 2004
Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactionsPatrick R Harrington, Jan Vinjé, Christine L Moe, et al.
Journal of Virology|March 3, 2007
Independent evolution of human immunodeficiency virus type 1 env V1/V2 and V4/V5 hypervariable regions during chronic infectionPatrick R Harrington, Julie A E Nelson, Kathryn M Kitrinos, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvirEric F Donaldson, Patrick R Harrington, Julian J O'Rear, et al.
Pageof 3